Comparison of CEA and CA۱۵-۳ Markers with Serotonin, Ceruloplasmin and Copper in Breast Cancer Recurrence after Chemotherapy

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 218

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ARCHB-8-4_009

تاریخ نمایه سازی: 9 آبان 1401

چکیده مقاله:

Background: The serotonin, copper, and ceruloplasmin markers are altered in various cancers, including breast cancer. It has been reported that these markers have the potential to be used in the study of cancer recurrence. The purpose of this study was to compare the levels of serotonin, copper and ceruloplasmin besides the routine breast cancer markers such as CEA and CA۱۵-۳ in the blood sample of patients with invasive ductal breast cancer, before and after chemotherapy.Methods: This study was performed on ۳۰ patients with breast cancer. Blood samples were taken from the patients before and after chemotherapy. Necessary data including age, tumor grade and status of HER-۲, ER, PR receptors were obtained from patient records. Serotonin, CEA and CA۱۵-۳ levels were measured by ELISA method. Ceruloplasmin and copper were measured by nephelometry and colorimetric methods, respectively.Results: Results showed a decrease in serotonin, ceruloplasmin, copper, CEA and CA۱۵-۳ after treatment but only the levels of serotonin and ceruloplasmin showed a steady decrease. No significant relationship was observed between tumor grade and ER-PR, HER-۲ receptors.Conclusion: This study showed that chemotherapy resulted in steady decline in serotonin and ceruloplasmin levels but this decrease was not steady in levels of CA۱۵-۳ and CEA. Therefore, if our results are confirmed by further research, they can be considered as a viable alternative to routine markers in cancer recurrence after chemotherapy.

کلیدواژه ها:

نویسندگان

Sahar Rezaei

Department of Clinical Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

Hemen Moradi-Sardareh

bDepartment of Clinical Biochemistry, Asadabad School of Medical Science, Asadabad, Iran

Mohammad-Hasan Khadem Ansari

Department of Clinical Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

Fatemeh Kheradmand

Department of Clinical Biochemistry, Faculty of Medicine, Cellular and Molecular and Solid Tumor Research Centers, Urmia University of Medical sciences, Urmia, Iran